Oral Appliance Maker ProSomnus Reports Record Revenue for 2023
The company reported a 43% increase in annual revenue for 2023, driven in part by greater adoption of its oral appliance therapy for obstructive sleep apnea.
The company reported a 43% increase in annual revenue for 2023, driven in part by greater adoption of its oral appliance therapy for obstructive sleep apnea.
Quality sleep can be hard to come by during a heat wave, especially for those who don’t have air conditioning.
Axsome Therapeutics' CRESCENDO survey finds 77% of narcolepsy type 1 patients continue to experience cataplexy attacks despite being treated.
Many sleep clinicians and researchers are on the market for new actigraphy devices after the discontinuation of Actiwatch support last December.
The company, known for research-based, FDA-listed sleep products for babies, children, and adults, is rebranding under a collective new brand identity.